Sepsis is a common presentation in the prehospital and retrieval environment, with most cases having a respiratory, urinary or soft tissue origin. However the best practice for identifying and management sepsis in the prehospital environment remains unclear. Despite sepsis having been a priority for in hospital guidelines and protocols for decades now, relatively little attention has been paid to prehospital sepsis management. Traditional teaching is that early antibiotics in sepsis save lives, however trials examining this are observational and confounded by outdated ICU care. An appropriately sensitive and specific tool for the prehospital identification of sepsis remains elusive. NEWS2 is common and lactate-modified QSOFA emerging (although prehospital lactate measurement remains difficult). The role of prehospital antibiotics, and the most appropriate one are also unclear. Most ambulance services that carry antibiotics use ceftriaxone. The retrieval environment is similar, with sepsis probably being the single commonest reason to call a retrieval service. For more head to our podcast page #CodaPodcast

1. SEPSIS WORKSHOP
Pfizer has aligned with global communicable disease experts to highlight
that antimicrobial resistance looms large as one of the most significant
threats to global health. We would like to thank Pfizer for supporting this
session and CODA 22 with an educational grant to support CODA
CURE: SEPSIS, PANDEMICS, TRAUMA & COMMUNICABLE
DISEASE.

2. SEPSIS
WORKSHOP – NO
ONE GETS LEFT
BEHIND
DERICK ADIGBLI

3. Acknowledgment of
Country
Built on the banks of the Birrarung (Yarra River), we acknowledge the
Traditional Owners of Narrm, the Boon Wurrung and Wurundjeri Woi
Wurrung people of the Kulin nation. We pay our respects to their Elders
past, present, and to Elders of all First Nations communities that visit
MCEC. We recognize the significance of the Birrarung to Traditional
Owners as a life source and a meeting place, and seek to honour a
40,000 year tradition of building community and exchanging ideas on
these lands.

4. Workshop organizing
committee
Associate Professor Naomi Hammond
Dr Amy Freeman-Sanderson
Dr Kelly Thompson
Dr Christopher Anderson
Dr Derick Adigbli

5. A PATIENT’S STORY

6. THE PATIENT JOURNEY

7. SEPSIS PANEL
DISCUSSION

8. SEPSIS WORKSHOP
Pfizer has aligned with global communicable disease experts to highlight
that antimicrobial resistance looms large as one of the most significant
threats to global health. We would like to thank Pfizer for supporting this
session and CODA 22 with an educational grant to support CODA
CURE: SEPSIS, PANDEMICS, TRAUMA & COMMUNICABLE
DISEASE.